Letter: proton pump inhibitor usage still seems to reduce the risk of high-grade dysplasia and/or oesophageal adenocarcinoma in Barrett's oesophagus--authors' reply.
Hvid-Jensen, F
Letter: proton pump inhibitor usage still seems to reduce the risk of high-grade dysplasia and/or oesophageal adenocarcinoma in Barrett's oesophagus--authors' reply. [electronic resource] - Alimentary pharmacology & therapeutics Oct 2014 - 860-1 p. digital
Publication Type: Letter; Comment
1365-2036
10.1111/apt.12931 doi
Adenocarcinoma--prevention & control
Barrett Esophagus--drug therapy
Esophageal Neoplasms--prevention & control
Esophagus--pathology
Female
Humans
Male
Proton Pump Inhibitors--therapeutic use
Letter: proton pump inhibitor usage still seems to reduce the risk of high-grade dysplasia and/or oesophageal adenocarcinoma in Barrett's oesophagus--authors' reply. [electronic resource] - Alimentary pharmacology & therapeutics Oct 2014 - 860-1 p. digital
Publication Type: Letter; Comment
1365-2036
10.1111/apt.12931 doi
Adenocarcinoma--prevention & control
Barrett Esophagus--drug therapy
Esophageal Neoplasms--prevention & control
Esophagus--pathology
Female
Humans
Male
Proton Pump Inhibitors--therapeutic use